Merck KGaA's Softly-Softly Approach To German Cutbacks Shows Learning From Swiss Experience
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck KGaA is in learning mode as it calls for early retirements and voluntary redundancies in Germany, instead of more abrupt action. Around 10% of jobs at Merck KGaA in Germany are at risk, but the company will refrain from forced job losses until the end of 2017.
You may also be interested in...
To Be “Fit For 2018,” Merck Serono Hints At Earlier Stage Deals, But India May Have To Wait
The world’s oldest drug maker is gearing up to be a leaner machine by 2018, relying on studying data closely before signing deals.
To Be “Fit For 2018,” Merck Serono Hints At Earlier Stage Deals, But India May Have To Wait
The world’s oldest drug maker is gearing up to be a leaner machine by 2018, relying on studying data closely before signing deals.
Sanofi Pulls Back On French Layoff Plans After Government Pressure
Sanofi says it will cut up to 900 jobs in France over the next three years to make its R&D operations there more efficient – that’s less than half the number foreshadowed in July by French trade unions and after the drug maker came under public pressure from the country’s left-wing government.